Dr. Yasir Rawjee is the Managing Director and Chief Executive Officer of our Company. He leads the overall operations of our Company and is responsible for the overall business strategy of our Company. He holds a bachelor’s degree in science from St. Xavier’s College, University of Bombay and a bachelor’s degree in science (technology) from University Department of Chemical Technology, University of Bombay. He also holds a PhD from Texas A&M University, U.S.A. He has over two decades of industry work experience and prior to joining our Company, he was the head of global API operations at Mylan Laboratories Limited. He was also the Senior Vice President at Matrix Laboratories Limited and has worked in GlaxoSmithKline in the USA.
Mr. Tushar Mistry is the Chief Financial Officer & Senior Vice President, leading the overall Accounts, Finance, Investor Relations & Secretarial function at Glenmark Life Sciences Limited. Tushar has over 24 years of experience in API & Formulation, handling Strategic & Tactical Planning, Investor Relationship, Budgetary Control, Fund Sourcing & Management, Mergers & Acquisitions & Business Partnering. He has recently joined the company in June 2022, from Sequent Scientific Limited, where he was working as a CFO. Prior to Sequent, he was associated with Wockhardt Limited. Tushar is a Chartered Accountant from ICAI and has completed his ICWA from Institute of Cost & Works Accountant of India.
Dr. Palle V R Acharyulu is the Group Vice President of the Research and Development (R&D) department and has been associated with our Company since July 14, 2020. He leads the research and development team to plan and execute API research and development. He also leads the project management and intellectual property functions of our Company. He holds a masters of sciences degree in chemistry from the University of Hyderabad and has completed the senior management programme from the Indian Institute of Management, Calcutta. He holds a PhD in chemistry from the University of Hyderabad. Prior to joining our Company, he has worked with Biocon Limited. He was also a Director at Dr Reddy’s Laboratories Limited. He has also been associated with Sun Pharmaceutical Industries Limited as a Senior Executive of the research and development (organic synthesis) department.
Mr. Vinod Naik is the Executive Director and Group Vice President and Head of the Technical Operation department of our Company and has been associated with the Company since March 12, 2020. He oversees the daily operations of the manufacturing plants such as production and manufacturing of APIs and intermediates. He is also responsible for the supply chain function of our Company. He holds a bachelor’s of science degree and a master’s of science degree from the Karnatak University, Dharwad. He has also completed a masters program in business administration with a specialization in financial management from the National Institute of Management. Prior to joining our Company, he was working with Sun Pharmaceutical Industries Limited. He has also been associated with Cipla Limited where was heading a manufacturing unit and has worked with Micro Labs Limited, as Vice President of the technical and operations department.
Mr. Sumantra Mitra is Head - Human Resources of our Company and has been associated with the Company since October 11, 2018. He is responsible for talent acquisition, talent management, capability development, organizational development and industrial relations, besides other aspects of the human resources agendas for our Company. He holds a bachelor’s degree in social work from Visva Bharati University and a master’s degree in social work from University of Pune. He holds a diploma in labour law and labour welfare from Symbiosis Society’s Law College, Pune. Prior to joining our Company he was the Vice President - Human Resources at Nilkamal Limited. He has also worked with Mahindra & Mahindra in the automotive sector and with Glenmark Pharmaceuticals Limited.
Mr. Mathew George heads Regulatory Affairs at Glenmark Life Sciences, where he oversees the regulatory compliance obligations that the organization needs to fulfil. This includes adhering to existing regulatory affairs requirements, keeping track of new & modified compliance status, periodic compliance testing and performing proactive assessments.
He has more than 26 years of rich experience in quality assurance and regulatory affairs. Mathew is responsible for all aspects of business continuity planning and disaster recovery, to safeguard the organization. He brings strong managerial and technical capabilities to Glenmark Life Sciences to ensure that all compliance needs, both domestic and international, are met. His expertise lies in planning, review and submission of new Drug Master Files (DMFs) / registration dossiers for filing with various regulatory agencies.
Prior to joining Glenmark, Mathew was the General Manager, Head of API Regulatory Affairs at Cadila Healthcare.
He joined the industry in 1995 with Shasun Chemicals & Drugs Ltd., where he was Head of Quality Assurance of the Pondicherry manufacturing facility and later handled the CQA and DQA functions. Mathew then moved to Marksans Pharma Ltd. as Head of QA & RA. He was also with Ranbaxy Laboratories Limited & Mylan Laboratories Ltd., where he handled the Regulatory Affairs function.
Mathew is a graduate in Chemistry from Loyola College, Chennai (April 1992) and holds a post-graduate degree in Inorganic Chemistry from I.I.T. Bombay (April 1994).
Mr. Navin Kumar Agrawal is Head Corporate Quality, API at Glenmark Life Sciences. He has almost three decades of experience in the industry, and is leading the Company’s global Quality & Compliance in accordance with cGMP & regulatory requirements for Active Pharmaceutical Ingredients (APIs). Since joining Glenmark Life Sciences, Navin has spearheaded the development and ongoing maintenance of robust quality management systems that ensure the Company’s statutory and regulatory duties are upheld. Prior to joining Glenmark Life Sciences, Navin was associated with Sun Pharmaceutical Industries Ltd. as Associate Vice President, Quality. He has also worked with Aurobindo Pharma Ltd. and Orchid Chemical & Pharmaceuticals. Navin holds an M.Sc. in Inorganic Chemistry from Barkatullah University, Bhopal, M.P. India
Mr. Mathew George is the Vice President and Head of Regulatory Affairs at Glenmark Life Sciences and has been associated with our Company since October, 2019. He leads the Regulatory Affairs team to plan and submit Drug Master Files (DMFs) / Registration dossiers with various Regulatory Agencies. He has over two decades of rich experience in Quality Assurance and Regulatory Affairs. Mr. Mathew completed his graduation in Chemistry from Loyola College Chennai and post-graduation in Inorganic Chemistry from I.I.T. Bombay. Prior to joining our Company, he has worked with Cadila Healthcare Limited as General Manager and Head of API Regulatory Affairs. Infact he joined the industry in 1995 with Shasun Chemicals & Drugs Limited and has also been associated with Marksans Pharma Limited as Head of QA & RA, as well as with Ranbaxy Laboratories Limited and Mylan Laboratories Limited handling the Regulatory Affairs function.